Lesley Liu‐Bujalski

602 total citations
10 papers, 346 citations indexed

About

Lesley Liu‐Bujalski is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Lesley Liu‐Bujalski has authored 10 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lesley Liu‐Bujalski's work include Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Lesley Liu‐Bujalski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Lesley Liu‐Bujalski collaborates with scholars based in United States, Italy and Switzerland. Lesley Liu‐Bujalski's co-authors include Jared Head, Roland Grenningloh, Federica Morandi, Andrew T. Bender, Philipp Haselmayer, A.S. Gardberg, Theresa Johnson, Yin Wu, Albertina Pereira and Lisa Bruns and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and Molecular Pharmacology.

In The Last Decade

Lesley Liu‐Bujalski

10 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Liu‐Bujalski United States 7 192 146 104 98 70 10 346
Dennis Demont Netherlands 6 280 1.5× 187 1.3× 206 2.0× 80 0.8× 109 1.6× 8 490
Bas van de Kar Netherlands 8 325 1.7× 150 1.0× 240 2.3× 90 0.9× 129 1.8× 10 462
Edwin de Zwart United States 6 252 1.3× 104 0.7× 191 1.8× 70 0.7× 106 1.5× 7 356
Kwee Hyun Suh South Korea 9 78 0.4× 141 1.0× 48 0.5× 45 0.5× 39 0.6× 32 341
Bart van Lith United States 7 319 1.7× 105 0.7× 240 2.3× 87 0.9× 131 1.9× 8 406
Jin Shu China 9 89 0.5× 111 0.8× 86 0.8× 52 0.5× 64 0.9× 18 285
Jennifer Postelnek United States 7 79 0.4× 86 0.6× 39 0.4× 119 1.2× 48 0.7× 12 269
Swaroop Vakkalanka United States 11 266 1.4× 210 1.4× 244 2.3× 131 1.3× 72 1.0× 46 551
Fanny Krantz United States 7 401 2.1× 129 0.9× 300 2.9× 128 1.3× 147 2.1× 12 495
Sujata Chakraborty United States 10 146 0.8× 286 2.0× 34 0.3× 40 0.4× 272 3.9× 17 541

Countries citing papers authored by Lesley Liu‐Bujalski

Since Specialization
Citations

This map shows the geographic impact of Lesley Liu‐Bujalski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Liu‐Bujalski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Liu‐Bujalski more than expected).

Fields of papers citing papers by Lesley Liu‐Bujalski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Liu‐Bujalski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Liu‐Bujalski. The network helps show where Lesley Liu‐Bujalski may publish in the future.

Co-authorship network of co-authors of Lesley Liu‐Bujalski

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Liu‐Bujalski. A scholar is included among the top collaborators of Lesley Liu‐Bujalski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Liu‐Bujalski. Lesley Liu‐Bujalski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Guler, Satenig, Alejandro Crespo, Richard D. Caldwell, et al.. (2023). Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression. ACS Medicinal Chemistry Letters. 14(5). 566–576. 14 indexed citations
2.
Haselmayer, Philipp, Montserrat Camps, Lesley Liu‐Bujalski, et al.. (2019). Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models. The Journal of Immunology. 202(10). 2888–2906. 108 indexed citations
3.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(20). 3307–3311. 4 indexed citations
4.
Liu‐Bujalski, Lesley, Richard D. Caldwell, Ariele Viacava Follis, et al.. (2018). Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit. Bioorganic & Medicinal Chemistry Letters. 28(17). 2939–2944. 19 indexed citations
5.
Caldwell, Richard D., Lesley Liu‐Bujalski, Igor Mochalkin, et al.. (2018). Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of Btk. Bioorganic & Medicinal Chemistry Letters. 28(21). 3419–3424. 15 indexed citations
6.
Caldwell, Richard D., Lesley Liu‐Bujalski, Andreas Goutopoulos, et al.. (2018). Discovery of Affinity‐Based Probes for Btk Occupancy Assays. ChemMedChem. 14(2). 217–223. 4 indexed citations
7.
Bender, Andrew T., A.S. Gardberg, Albertina Pereira, et al.. (2017). Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling. Molecular Pharmacology. 91(3). 208–219. 126 indexed citations
8.
Bender, Andrew T., Albertina Pereira, Kai Fu, et al.. (2016). Btk inhibition treats TLR7/IFN driven murine lupus. Clinical Immunology. 164. 65–77. 38 indexed citations
9.
Haselmayer, Philipp, Montserrat Camps, Lesley Liu‐Bujalski, et al.. (2016). THU0275 Pharmacodynamic Modeling of BTK Occupancy versus Efficacy in RA and SLE Models Using The Novel Specific BTK Inhibitor M2951. Annals of the Rheumatic Diseases. 75. 286–287. 3 indexed citations
10.
Karra, Srinivasa, Yufang Xiao, Xiaoling Chen, et al.. (2013). SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3081–3087. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Demont Breakdown of academic impact, for papers by Bas van de Kar Breakdown of academic impact, for papers by Edwin de Zwart Breakdown of academic impact, for papers by Kwee Hyun Suh Breakdown of academic impact, for papers by Bart van Lith Breakdown of academic impact, for papers by Jin Shu Breakdown of academic impact, for papers by Jennifer Postelnek Breakdown of academic impact, for papers by Swaroop Vakkalanka Breakdown of academic impact, for papers by Fanny Krantz Breakdown of academic impact, for papers by Sujata Chakraborty
Rankless by CCL
2026